BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  Intercept to Report 2017 Full Year Financial Results on February 14 and Present at Upcoming Conferences

  Management will conduct a conference call and audio webcast on Wednesday, February 14, 2018 at 8:30 a.m. Eastern Time to discuss these results.

  February 8, 2018

   · 

  1 min read
• Drug Development

  CILcare’s Age-Related Hearing Loss Model Enriched With NAC as Positive Control

  The antioxidant, NAC, delays the senescence process by slowing the age-related hearing loss and protecting cochlear hair cells of SAMP8 mice.

  February 8, 2018

   · 

  3 min read
• joimax Continues Strong Growth Trend in 2017 with Launch of Its MultiZYTE Facet and SI Joint Treatment Set in the U.S.

  The joimax announces very strong sales figures for 2017.

  February 8, 2018

   · 

  3 min read
• Deals

  Sanofi Commences Tender Offer for Acquisition of Bioverativ

  The Offer is being made pursuant to the Agreement and Plan of Merger, dated as of January 21, 2018.

  February 8, 2018

   · 

  9 min read
• Drug Development

  Sanofi Announces New Safety Data for Investigational Avalglucosidase Alfa in Patients With Pompe Disease

  The study results were presented today at the 14th Annual WORLDSymposium 2018 in San Diego, California.

  February 8, 2018

   · 

  4 min read
• Business

  AnaBios Announces Agreement to Develop Atrial Fibrillation Treatment

  The program will focus on compounds designed to modulate a novel cardiac ion channel target.

  February 8, 2018

   · 

  1 min read